ArticleCureus2026
Improved In-Hospital Outcomes for a Ruptured Abdominal Aortic Aneurysm Over Time: A Single-Center Retrospective Analysis of 58 Cases.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAt our institution, open surgical repair (OS) is the first-line treatment for ruptured abdominal aortic aneurysms (rAAA). This study aimed to evaluate in-hospital and long-term outcomes of rAAA treatment in a community hospital setting and to assess temporal changes in management, including operative delay (time to surgery), and survival.
methodsWe retrospectively analyzed 58 patients (mean age: 74 ± 9 years; male: n = 47) who underwent emergency surgery for rAAA between November 2012 and March 2025. OS was performed as the primary treatment strategy in 51 cases, whereas EVAR was selectively performed in seven hemodynamically stable patients with suitable anatomy when an appropriate stent-graft device was available.
resultsIn-hospital mortality rate was 13/58 (22.4%), all in the OS group. Deaths were due to multiple organ failure (n = 6), sepsis (n = 3), bowel necrosis (n = 2), and hemorrhage (n = 2). Mortality rate decreased from 37.9% (11/29) in the early group to 6.9% (2/29) in the late group, with shorter time to surgery (median: 109 vs. 217 minutes; p = 0.01). The five-year survival rate was 58% ± 7%.
conclusionA shorter time to surgery contributed to improved outcomes in patients with rAAA. Even when OS is adopted as the primary strategy, rapid surgical intervention can lead to favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.